Brain Aging - review of ENIGMA: 47 countries, 200+ studies

Neuroscientists Found the Fastest Way to Reverse Brain Aging (And It's Not What You Think)

YouTube - Oct 2026, 85 minutes

Summary by Claude AI

  • (00:00–04:35) Paul Thompson leads the ENIGMA Consortium — ~2,500 scientists in 47 countries, ~200,000 brain scans across 30+ disorders — combining imaging with blood biomarkers to study psychiatric as well as neurological disease; Hyman notes the DSM-5 describes symptoms with "100% accuracy, 0% validity" about cause.
  • (04:52–07:33) Alzheimer's incidence roughly doubles every 5 years after age 70; serial MRIs show a "wildfire" of tissue loss starting in memory systems, then language, then frontal planning areas — now used as a biomarker endpoint in drug and lifestyle trials, including early Lilly schizophrenia work showing slowed tissue loss on medication.
  • (09:50–14:03) Standard structural MRI misses psychiatric illness (e.g., bipolar looks "normal"); functional MRI and PET reveal blood flow, metabolism and network synchrony, which can be reset by metabolic, keto, or pharmacological interventions and used to confirm treatment response.
  • (16:44–23:01) Common roots across disorders: inflammation, mitochondrial and metabolic dysfunction. Colleague Thomas Hajek found cardiometabolic disease (high BMI, often caused by antipsychotics themselves) produced far greater brain changes in schizophrenia, bipolar and depression than the psychiatric diagnosis alone — treating the body improves the brain.
  • (23:20–26:34) Two broad imaging patterns: "internalizing" disorders (depression, anxiety, bipolar lows) show limbic/"gas pedal" deficits and glutamate abnormalities; compulsive/addictive disorders (OCD, substance abuse, ADHD, mania) show frontal-lobe/"brakes" damage.
  • (29:55–34:45) Strongest lifestyle signals from ENIGMA: obesity makes the brain look ~8 years older; low estrogen, testosterone or thyroid accelerates brain aging; high homocysteine (correctable with folate/B vitamins) is harmful, and fixing nutrient deficits shows measurable improvement on scans. "Brain age" is a composite of hippocampal volume, white-matter connectivity, and blood flow plotted on percentile brain charts.
  • (35:09–39:39) Hyman reports an 8% rise in cortical thickness and 22% drop in white-matter lesions on quantitative MRI after ibogaine in Mexico. Thompson: the brain regenerates — anorexia had the largest brain effect of any psychiatric disorder studied, yet renourishment restored all systems; sleep clears waste via the glymphatic system.
  • (40:28–43:43) Depression and bipolar show sluggish switching between resting-state networks (e.g., overactive default-mode/rumination network); SSRIs, TMS, neurofeedback, CBT and metabolic approaches all shift that balance, with AI now used to detect when synchrony returns to normal.
  • (50:51–57:15) Genetics tilt rather than determine risk: only ~2% of Alzheimer's is presenilin/APP-driven; APOE4 raises risk 3–10× but is weaker in African ancestry (a nearby protective variant) and strongest in East Asians. The AI4AD project uses polygenic subtypes (inflammation, amyloid, tau, immunity) for genome-guided drug repurposing, tested on engineered stem-cell neurons.
  • (1:01:20–1:19:06) Emerging diagnostics: brain charts (NeuroQuant-style quantitative MRI), 11,000-protein proteomic panels, and blood markers pTau-217, Aβ42/40, NfL and GFAP; Thompson predicts combined scan-plus-blood diagnosis of all major neuro-psychiatric conditions within 5–10 years. Dementia has many subtypes beyond amyloid (Lewy body, TDP-43/LATE, vascular), each needing different treatment; brain changes are visible up to 30 years before Alzheimer's symptoms.

ENIGMA Consortium several hundred papers since 2009

ENIGMA = Enhancing NeuroImaging Genetics through Meta-Analysis

Consortium overviews

  • Thompson et al., 2014, Brain Imaging and Behavior — the founding description of ENIGMA's structure and methods [Thompson 2014]
  • Thompson et al., 2020, Translational Psychiatry — ten-year review covering 40+ countries and 50+ working groups [Thompson 2020]

Imaging genetics (GWAS of brain structure)

  • Stein et al., 2012, Nature Genetics — first ENIGMA GWAS; common variants for hippocampal and intracranial volume [Stein 2012]
  • Hibar et al., 2015, Nature — subcortical volumes in ~30,000 people, including the KTN1 locus for putamen [Hibar 2015]
  • Adams et al., 2016, Nature Neuroscience — intracranial volume GWAS [Adams 2016]
  • Satizabal et al., 2019, Nature Genetics — subcortical structures in 38,851 individuals [Satizabal 2019]
  • Grasby et al., 2020, Science — genetic architecture of cortical surface area and thickness (~51,000 people); probably the single most-cited ENIGMA paper [Grasby 2020]

Disease working groups (case–control meta-analyses)

Brain organization / normative work

  • Kong et al., 2018, PNAS — brain asymmetry across 17,000+ people [Kong 2018]
  • Frangou et al. and Dima et al., 2022, Human Brain Mapping — lifespan reference charts for cortical thickness and subcortical volumes (ages 3–90)

A common thread: most of these find small effect sizes (Cohen's d ≈ 0.1–0.3) that only become reliable at the multi-thousand-subject scale ENIGMA made possible, which reshaped expectations for psychiatric neuroimaging. If you want the newest work (e.g., the ENIGMA-ECT, lithium, or rare-CNV papers from 2023–2026), I can run a quick search.

Recent ENIGMA work (2023–2026)

  • Constantinides et al., 2023, Molecular Psychiatry — brain ageing in schizophrenia across 26 cohorts; and Schijven et al., 2023, large-scale structural asymmetries in schizophrenia [UNIR listing]
  • Ge et al., 2024, Lancet Digital Health — CentileBrain, normative lifespan brain-morphometry models benchmarked on ENIGMA data; and a 2024 Scientific Reports paper on combining non-equivalent cognitive measures across ENIGMA cohorts [UNIR listing]
  • van Velzen et al., 2022, Mol Psychiatry — ENIGMA-STB mega-analysis of 21 studies from ten countries on brain structure and suicidal thoughts/behaviors in people aged 8–25 [van Velzen 2022]

2025

  • Silva et al., 2025, Biol Psychiatry: CNNI — ENIGMA-CNV pooled MRI and genetic data from 22 cohorts and found that higher CNV penetrance for schizophrenia and developmental disorders tracked with lower cortical surface area and intracranial volume [Silva 2025]
  • Başgöze et al., 2025, Mol Psychiatry — regional brain morphology and current antidepressant use across 32 ENIGMA-MDD cohorts [Başgöze 2025]
  • van Velzen et al., 2025, Translational Psychiatry — ENIGMA-STB white-matter mega-analysis found subtle regional and global microstructural alterations in people with a history of suicide attempt [van Velzen 2025]
  • ENIGMA-Meditation, 2025, Biol Psychiatry: CNNI — launch paper for the first worldwide consortium for neuroimaging of meditation practices [ENIGMA-Meditation]
  • Ousdal et al., 2025, Communications Medicine (GEMRIC) — in 435 patients, ECT enlarged the hippocampal head more than body or tail, and posterior-hippocampal change related to cognitive side effects [Ousdal 2025]; the foundational GEMRIC paper is Oltedal et al., 2018, which found hippocampal volume rose ~0.28% per ECT session but was not positively associated with clinical outcome [Oltedal 2018]

2026 (preprints, not yet peer-reviewed)

  • Nugent et al., bioRxiv — the ENIGMA MEG pipeline for automated multi-site resting-state MEG analysis [Nugent 2026]
  • Blake et al., medRxiv — ENIGMA-Anxiety brain-age mega-analysis across 26 cohorts found no advanced brain ageing in social anxiety disorder overall, though a +2.4-year gap in those with comorbid anxiety disorders [Blake 2026]
  • ENIGMA Antisocial Behavior WG, bioRxiv — brain age in conduct disorder, mean brain-PAD +0.45 years [Conduct disorder 2026]
  • Jin et al., medRxiv — altered neurodevelopmental trajectories in Tourette syndrome and chronic tic disorders [Jin 2026]

Lithium: the main published synthesis is Ching et al., 2022, Human Brain Mapping, the ENIGMA-BD working-group review, which covers brain alterations associated with lithium and other common medications [Ching 2022]; a dedicated lithium–hippocampal-volume mega-analysis was presented at OHBM 2022 [OHBM abstract] but I did not find a journal version.

Two broader developments: the India ENIGMA Initiative on brain aging and mental health launched in 2023 Wikipedia, and the consortium has shifted noticeably from case–control volumetrics toward brain-age, normative-modelling and transdiagnostic designs.

Interview of Dr. Paul Thompson - Oct 2026

Summary of [Hyman podcast with Paul Thompson]. Mark Hyman interviews USC neuroscientist Paul Thompson, who leads the ENIGMA consortium.

  • 00:18–03:57: ENIGMA is a global brain-mapping collaboration: about 2,500 scientists in 47 countries, roughly 200,000 brain scans, and more than 30 disorders, with blood biomarkers added. Hyman quotes Thomas Insel's view of the DSM-5: "100% accuracy, 0% validity." The DSM sorts symptoms but doesn't explain causes.
  • 04:25–07:44: Alzheimer's affects about 5% of 70-year-olds and doubles every 5 years after that (10% at 75, 20% at 80). Repeated scans show tissue loss spreading from memory to language to frontal regions. That made imaging a readout for drug trials, including Lilly's schizophrenia work, where an antipsychotic slowed tissue loss.

  • 08:15–28:47: Psychiatric and neurologic disorders share common roots: inflammation, oxidative stress, and mitochondrial and metabolic dysfunction. Functional MRI and PET (blood flow, metabolism, resting-state networks) show what structural MRI misses. Two broad patterns appear:

    • Depressive or "internalizing" disorders involve the limbic "gas pedal."
    • Compulsive or disinhibited disorders (addiction, OCD, mania, ADHD) involve the frontal "brakes."
  • 19:06–22:35: About 60% of people diagnosed with dementia have cardiometabolic problems that are often treatable. In schizophrenia, bipolar disorder, and depression, high BMI or metabolic disease went with much worse brain scans. Some antipsychotics cause weight gain, which adds to the damage.

  • 29:28–34:05: "Brain age" is a composite score from many MRI measures. Factors linked to older-looking brains:

    • Obesity or overweight (about 8 years older)
    • Below-normal estrogen or testosterone
    • Out-of-range low thyroid
    • High homocysteine (lowering it with folate and B vitamins showed measurable improvement on brain scans in trials)
  • 34:34–36:11: Hyman, age 66, describes his own ibogaine experience in Mexico. On quantitative MRI, cortical thickness rose 8% and white-matter lesions fell 22% three months later. This is a single, uncontrolled self-report.
  • 36:29–39:44: During sleep, the glymphatic system flushes waste from the brain, so poor sleep speeds decline. Anorexia had the largest brain effect of any psychiatric disorder ENIGMA studied, and it largely reversed with renourishment. Thompson's point: the brain can recover more than medical teaching assumes.
  • 50:43–56:48: Genetics:
    • Only about 2% of Alzheimer's is directly inherited (presenilin and APP genes).
    • APOE4 tilts risk but doesn't determine it. About 25% of people carry one copy and about 6% carry two, with up to 9–10× higher risk.
    • The effect varies by ancestry. It is weaker in people of African ancestry, possibly because of a nearby protective variant.
    • Researchers are matching existing approved drugs to a patient's genetic profile.
  • 59:41–1:11:16: "Brain charts" place a person's brain measures on percentile curves, like a child's growth chart. Newer blood markers for dementia include p-tau217, Aβ42/40, neurofilament light, and GFAP. Thompson predicts that within 5–10 years, scans plus blood markers could diagnose the major neurologic and psychiatric conditions. Hyman separately lists vitamin D, iron, omega-3, heavy metals, insulin, thyroid, sex hormones, homocysteine, and methylmalonic acid as brain-relevant tests. Vitamin D is only named in that list; no data is given for it.
  • 1:12:24–1:17:13: The AI4AD project uses AI to sort dementia into subtypes: amyloid, Lewy body/synuclein, LATE/TDP-43, and vascular. Each subtype may need different treatment, and vascular forms point to cardiometabolic and lifestyle fixes.

The title's "fastest way" is never actually identified. The closest thing is Hyman's ibogaine anecdote. A good share of the runtime is sponsor ads and promotion of Function Health and Hyman's new book.

No mention of Vitamin D, Bredisen, etc.?